sisted of 50 female and 23 male patients with a mean age of 44.85 Ϯ 13.78 years (range 10-75 years); four patients were children. Follow ups ranged from 6 to 144 months with a median of 45.4 months.
Ophthalmological examinations involved testing the patient's best corrected visual acuity with a Snellen chart 15 at a 5-m distance, funduscopy, and Goldmann perimetry for visual field defects. Ocular motor function was evaluated, as was the degree of proptosis (Hertel exophthalometer). Follow-up examinations were performed every 3 to 6 months.
All patients underwent evaluation by computerized tomography and/or MR imaging with and without contrast agent. High-resolution axial and/or coronal computerized tomography best revealed bone changes in the region of the optic canal, anterior clinoid process, and superior orbital fissure. Both T 1 -and T 2 -weighted MR imaging was performed in three planes. Fat-suppressed MR imaging was used to distinguish enhancing pathological lesions from normal anatomy. Magnetic resonance follow-up examinations for possible tumor progression were scheduled at 3 and 12 months postoperatively, after which MR control studies were conducted yearly.
Information on clinical history, signs, surgical approach, and outcome was obtained retrospectively by reviewing the patient charts and radiological reports.
Surgical Procedures
Almost all surgery was performed via a unilateral frontotemporal approach. This pterional approach has been well described in the literature. 10, 16, 24 For intradural procedures, the sylvian fissure is routinely opened. Drainage of cerebrospinal fluid is performed by opening the basal cisterns and by lumbar drainage. The ipsilateral optic nerve and carotid artery are identified, and the intracranial tumor is first co-FIG. 1. Drawings of different types and subtypes of ONSMs according to their location. Upper: Type I, purely intraorbital lesions numbered eight among our patients. Type Ia is a flat tumor extension around the optic nerve (one patient, left), Ib is widespread; it presents as a large bulbiform mass around the optic nerve (four patients, center), and Ic is an exophytic tumor on the optic nerve (three patients, right). Center: Type II, intraorbital ONSMs with extension through the optic canal or superior orbital fissure numbered 36 among our patients. Type IIa represents an intraorbital tumor with growth through the optic canal (32 patients, left) and IIb represents tumors of the apex, superior orbital fissure, or cavernous sinus (four patients, right). Lower: Type III, intraorbital lesions with widespread intracranial tumor extension numbered 29 among our patients. Type IIIa ONSMs are intraorbital with intracranial extension to the chiasm (21 patients, left) and IIIb lesions are intraorbital with widespread intracranial extension to the chiasm, contralateral optic nerve, and planum sphenoidale (eight patients, right). agulated and resected along the dura mater around the optic canal. Preservation of the small feeding vessels between the carotid artery and the optic nerve is important and can be reached by aspirating the tumor within the arachnoidal plane. At this point mainly irrigation instead of coagulation should be used. The ipsilateral optic canal should be opened. We favor early lateral opening of the dural portion of the optic canal to avoid narrowing of the optic nerve through this band. The dura mater is resected around the optic canal and the optic canal bone is decompressed. Drilling should begin laterally until the floor of the optic canal is reached to prevent any contact with the nerve. Finally, the optic canal is unroofed. In cases of opening the medially located sphenoid sinus or ethmoidal cells, subcutaneous tissue with fibrin glue is inserted. The first 2 to 3 mm of the intracranial portion of the canal are fibrous, and the optic nerve can be exposed by opening this band. The optic nerve sheath is opened until the annulus of Zinn is reached (beyond this area the tumor is not amenable). The tumor around the optic nerve and the dura mater is carefully removed. In tumors infiltrating the nerve, resection is limited to the exophytic part. In blind patients with disfiguring painful proptosis, the optic nerve is transsected and the intraorbital portion is removed.
In tumors without intracranial extension, an extradural approach is favored together with sphenoid ridge drilling, posterior orbitotomy, decompression of the superior orbital fissure, and unroofing of the optic canal. We do not attempt complete excision in the apex, superior orbital fissure, or cavernous sinus.
Tumors with exophytic intraorbital mass are amenable to excision via a lateral orbitotomy.
Results

Classification System
We introduced a new classification system for ONSM according to tumor location (Fig. 1) . Type I lesions are located purely intraorbitally (eight meningiomas). Type Ia lesions are restricted to a flat extension around the optic nerve (one meningioma). Type Ib lesions manifest as a large bulbiform mass (four meningiomas) growing concentrically around the optic nerve with marked proptosis. Type Ic tumors show exophytic growth on the optic nerve (three meningiomas).
Type II lesions are located intraorbitally with extension through the optic canal or superior orbital fissure (36 meningiomas). Type IIa tumors manifest intraorbitally with growth through the optic canal (32 meningiomas). Type IIb lesions involve the orbital apex (four meningiomas) and the superior orbital fissure and sometimes even infiltrate the cavernous sinus.
Type III ONSMs are located intraorbitally with far-reaching intracranial extension (Ͼ 1 cm, 29 meningiomas). Type IIIa lesions extend to the chiasm (21 meningiomas), whereas Type IIIb involve the chiasm up to the contralateral optic nerve and the planum sphenoidale (eight meningiomas).
Intracranial extension could be diffuse grasslike (65%) or nodular (35%; Fig. 2 ).
Signs and Symptoms
The mean duration of symptoms was 25.1 months (range 1-144 months). The shortest duration of symptoms leading to surgery was observed in ONSM Types Ic and IIa, the longest duration in Types Ia and Ib ( Table 1 ). The preoperative duration of symptoms negatively correlated with preoperative visual acuity (Spearman correlation coefficient r = Ϫ0.3, p = 0.005).
On admission, 34 patients had good vision (Snellen notation Ն 0.5); 17 fair vision (Snellen notation Ͻ 0.5-Ͼ 0.1); and 22 no useful or poor vision (Snellen notation Յ 0.1-0; Table 2 ). Fourteen patients in the good vision group presented with normal vision, but four had marked proptosis, three disc swelling, and seven visual field defects ( IIIb 60 0 0 0 1, t * FU = follow up; O = optic disc swelling; P = proptosis; t = transection of optic nerve; V = visual field defect. † 1 = intradural pterional approach; 2 = extradural posterior orbitotomy; 3 = combined procedure; 4 = lateral orbitotomy.
tients, of whom seven had no useful vision. Seven patients had primary bilateral ONSMs. Two patients had a history of trauma, and in three patients there was a continuous spread of the ONSM on the contralateral side.
Results of funduscopy revealed optic disk pallor in 24 patients, six of whom showed bilateral affection. Disc swelling occurred in 12 patients and optociliary shunt vessels appeared in six. Visual field defects were diagnosed in 32 patients with useful vision. Proptosis was a main symptom in 29 patients, with marked proptosis (Ͼ 4 mm) in five. Oculomotor disturbance related to mechanical restriction of extraocular muscles was present in 15 patients, and an isolated oculomotor or abducens paralysis in three patients each.
General History and Genetics
Four patients suffered from neurofibromatosis Type 2; two of them had first-degree relatives with the disorder. Two patients harbored multiple meningiomas (tentorial, foramen magnum, petroclival, convexity, falcial, and sphenoid wing meningiomas). One of them had undergone decompression of the contralateral optic canal 5 years earlier.
Another patient had undergone surgery for frontobasal glioma on the contralateral side (astrocytoma World Health Organization II), and one patient an operation for optic glioma on the ipsilateral side. Seven patients had previously undergone surgery for another meningioma at a different location. Seven patients had undergone surgery for ONSMs (three patients with one prior operation, three with two operations, and one with four) in other neurosurgical departments and were referred to our center for repeated surgery. Two patients had suffered thrombosis of the central retinal artery with subsequent blindness. Three tumors had been misdiagnosed at another center and treated as sarcoidosis, optic neuritis, and papillitis.
Surgical Procedure
The standard surgical approach in 54 patients was the intradural pterional approach with decompression of the optic canal and no resection of the intraorbital flat tumor around the optic nerve (Table 1) . Seven patients underwent a combined intra-and extradural approach together with intradural inspection of the optic nerve. Ten intracranial extensions were detected intraoperatively but had not been revealed on preoperative MR images. On the other hand, intracranial extension could not be confirmed in three patients because the tumor was still restricted to the canal. The extradural approach with posterior orbitotomy was restricted to 10 patients with purely intraorbital meningiomas. Two patients underwent surgery via lateral orbitotomy. In total, seven patients underwent open diagnostic biopsy. Nine patients with amaurosis and prechiasmal affection of the optic nerve underwent transection of the optic nerve. Orbital tumor invasion extended beyond the optic nerve into the globe in two patients, and an enucleation of the eye was performed by an ophthalmologist.
The surgical approach (Kruskal-Wallis test, not significant) did not influence postoperative visual acuity. Tumor specimens in patients who had undergone biopsy alone demonstrated better pre-and postoperative visual acuity (Kruskal-Wallis test, p = 0.03).
Surgical Complications
Two patients suffered from infarction: one partial infarction of the contralateral middle cerebral artery area with aphasia and one complete infarction of the ipsilateral middle cerebral artery area with hemiparesis. Three patients had a temporary cerebrospinal fluid fistula and were sufficiently treated using lumbar drainage. One epidural hematoma required repeated surgery and two subdural hygromas were punctured. Two patients suffered from an epileptic seizure in the 1st postoperative week. One patient required antibiotic therapy for meningitis. The transient morbidity rate was 12.3%, and the permanent morbidity rate 2.7%.
Postoperative Outcome
On hospital discharge, the postoperative visual acuity did not significantly differ from preoperative acuity (Wilcoxon test, not significant). Patients remained stable within the three different visual categories (chi-square test, p = 1.62 ϫ 10 -12
; Table 2 ). Age did not correlate with pre-or postoperative visual acuity (Spearman correlation coefficient, not significant). The type of tumor had no significant impact on postoperative visual acuity (Kruskal-Wallis test, not significant).
Proptosis resolved completely in four patients, incompletely in 13, and remained unchanged in 12. Ocular motility recovered in six patients. Nonetheless, postoperative new transient ptosis and/or oculomotor paresis occurred in four patients each (Table 1) .
Follow-Up Studies
Vision worsened during an extended follow-up period (Spearman correlation coefficient r = Ϫ0.3, p = 0.004). Furthermore, vision at follow up significantly differed from postoperative vision (Wilcoxon test, p = 0.05). Note, however, that most patients remained stable within the three different vision groups (chi-square test, p = 9.53 ϫ 10 -13 ). Patients with good postoperative vision retained this faculty (27 patients), but eight patients' vision worsened (Table 3) . Poor vision did not improve at follow up (27 patients) except in one patient. In the group with fair acuity, one pa- tient's vision improved and four patients' worsened ( Table  3 ). The visual acuity in 59 of 73 patients remained unchanged. The tumor type did not significantly influence visual acuity at follow up (Kruskal-Wallis test, not significant), although the worst visual acuity was noted in patients with Type Ia and IIIb tumors.
Results of Radiotherapy
Ten patients with ONSMs underwent postoperative radiotherapy ( Table 1) . Two of the lesions infiltrated the intracranial optic nerve, and biopsy specimens of two additional tumors alone were obtained. Five patients received stereotactic fractionated conformal radiation (50-60 Gy) for treatment of residual tumors (four patients) or progression of the disease (one patient). Four patients (three with residual tumors, one with a recurrent tumor) underwent conventional radiation with 44 to 54 Gy over a 6-week period. One recurrent tumor was treated using gamma knife (14 Gy). Vision improved in one patient, remained unchanged in five, and deteriorated in four.
Growth of Residual Tumor
Growth of residual tumor occurred in 13 cases (17.8%) a mean of 59.2 months (range 14-98 months) postoperatively; three of these patients with good vision underwent additional radiotherapy. Eight patients harboring meningiomas with intracranial extension underwent repeated surgery, and two patients with clinically asymptomatic tumors were only observed. Two patients suffered from multiple intracranial meningiomas. The duration of follow up positively correlated with the growth of residual tumor (U-test, p = 5.42 ϫ 10
Ϫ7
). Eight tumor progressions occurred more than 60 months postoperatively. Note that the extent of initial resection, the surgical approach, or the tumor subtype did not influence the incidence of tumor progression (chi-square test, not significant), although six of the eight tumor progressions involved Type IIa lesions.
Discussion
Pathological Features and Pathogenesis
Primary ONSMs arise from the arachnoid cap cells surrounding the intracanalicular or intraorbital portion of the nerve and are almost always intimately associated with the nerve tending to surround the nerve. 18 These factors result in a concentric thickening of the optic nerve diameter. Optic nerve sheath meningiomas extend posteriorly into the annulus of Zinn; therefore, ONSMs cannot be resected completely without compromising the integrity of the optic nerve. 12 There are different mechanisms of preoperative optic nerve injury: ischemia, compression, demyelination, 12 and tumor invasion. 9 Compressive mechanical injury leads to small vessel compromise and demyelination, especially in patients who have experienced a long duration of visual loss before surgery. Assuming that there is no additional intraoperative trauma to the optic nerve, incomplete or no recovery of visual function after surgery may imply chronic severe preoperative ischemic or compressive damage and demyelination. The optic canal bone is not enlarged in ONSMs and the tumor in the canal compresses the optic nerve. This compressive injury can at least be reversed by surgical bone decompression of the optic canal. This is the main argument in favor of surgery.
Aggressive ONSMs are known to infiltrate the globe or optic nerve. Thus, deterioration of visual acuity may also result from direct tumor invasion into the intracranial optic nerve (four patients). Infiltration of the globe occurred in two patients and infiltration of the cavernous sinus in four patients (Type IIb lesions). Irregular margins in the orbit implied local invasion. 25 
Lesion Location
Tumor location seems to have an important impact on the evolution of visual function. The onset of visual loss in patients with an ONSM at or near the orbital apex is thought to be followed by additional rapid and progressive visual loss 3, 5 and involves a higher risk of intracranial extension. We also identified an intracanalicular location as a negative factor for visual acuity. Saeed, et al., 25 demonstrated that tumors with posterior components in the orbit more frequently had intracranial involvement. Intracranial extension was more frequent and was associated with faster growth rate in younger patients. 25 In cases in which ONSM involves the intracanalicular portion of the nerve, up to a 38% incidence of contralateral nerve involvement has been reported. 7 Thirty-six of our patients revealed intracanalicular extension (Type IIa lesion) and 29 showed widespread intracranial extension (Type III lesion; Table 1 ). Twenty-one patients demonstrated spread to the chiasm (Type IIIa lesion) and eight to the contralateral side (Type IIIb lesion). The high percentage of intracranial extension buttresses our use of surgical intradural inspection and tumor removal.
Type IIIb tumors with far-reaching intracranial extension to the chiasm, contralateral optic nerve, and planum sphenoidale can be easily removed from the skull base in contrast to tuberculum sellae meningiomas with an intracranial origin. Patients with tuberculum sellae or sphenoid wing meningiomas have a substantially better visual outcome following surgery than those with ONSM. Furthermore, these tumors may invade the optic canal but do not grow along the intraorbital optic nerve sheath. The Type IIIb ONSMs surround the entire intraorbital optic nerve and extend intracranially through the optic canal.
Although tumor type had no significant prognostic relevance to the evolution of visual acuity, patients with Type Ia and IIIb lesions presented with poor visual acuity on follow up. Five of the Type IIIb tumors showed bilateral intraorbital tumor growth. In the future, we would prefer to administer radiotherapy at an earlier point in time in patients with these tumors. 
Outcome and Surgery
The natural history of ONSMs is characterized by a gradual, unremitting loss of vision. 2, 13 Visual acuity better than 20/50 on presentation correlated with longer preservation of vision. 25 Note that these tumors are not associated with significant neurological morbidity or death. 18 Very few cases of visual improvement after microsurgical resection of ONSMs have been reported, but the lesions in these cases represent a subset located far anteriorly, just posterior to the globe. 9, 11, 13 Authors of other surgical series have reported a high rate of visual complications (30-40%) such as central retinal artery occlusion, motility disturbance, visual field defect, and a high rate of recurrence (65%). 3, 7, 11 Therefore, excision has been used to treat blind, uncomfortable, or unsightly eyes and to reduce the risk of intracranial or contralateral extension. 3, 7, 11, 29 In patients with tumors confined to the optic canal, decompression of the canal may be associated with vision stabilization lasting for years. Optic sheath opening along the length of the nerve within the optic canal to the annulus of Zinn relieves any focal circumferential pressure on the optic nerve. 12 Conversely, Saeed, et al., 25 could not detect preservation of vision by optic sheath decompression. If there is evidence of tumor spread across the planum sphenoidale and useful vision is still present, only the intracranial portion of the tumor with preservation of the optic nerve can be removed to prevent spread to the contralateral optic nerve. 29 In our series, visual deterioration was observed in 10 patients postoperatively and visual improvement in six patients (Table 2) . Fifty-seven patients maintained their vision. Thus, we were able to demonstrate that it is possible to perform surgery without causing significant visual loss. At follow up, one patient with fair vision showed delayed improvement following surgery (Case 58; Table 1 ). Visual deterioration in patients with ONSM usually is only a matter of time. In our series, visual acuity became worse with longer duration of preoperative symptoms and longer follow-up period.
We mainly used the intradural, extradural, or combined pterional approach with good results. Two operations were performed via lateral orbitotomy. Orbitozygomatic resection has been used by some authors to treat orbital or sphenocavernous meningiomas. 4, 6, 17 We used this approach for extended tumors located in the laterobasal aspect of the orbit or in the apex or those extending from the orbit to the superior orbital fissure and temporal fossa. 24 Regardless, in patients with ONSMs we do not attempt complete excision of the tumor. In our opinion, the orbitocygomatic approach is too extended to perform subtotal resections in infiltrative ONSMs. The superior orbital fissure and the optic canal are well decompressed via a pterional approach. Any residual tumor can be irradiated.
Radiotherapeutic Options
Radiotherapy has assumed a new role and is increasingly being offered to adults as primary therapy once mild to moderate vision loss develops. Success with conventional radiotherapy has been reported, although radiation-induced necrosis occurs in up to 15% of patients. 2 Radiation optic neuropathy may occur from months to years after exposure of the nerve. Factors contributing to optic neuropathy include an excess of 60 Gy radiation and fractionated doses greater than 1.9 Gy. 22 The mechanism of injury is unknown but has been postulated to be caused by damage to endothelial cells of blood vessels. 2 New techniques, including stereotactic radiosurgery, conformal radiation, and intensity modulation, have been developed to reduce the complications.
Turbin, et al., 28 provided substantial data indicating that conventional radiotherapy is associated with the best visual outcome during the follow-up period. They recommended fractionated external-beam radiation (5000-5500 cGy). Visual acuity fell significantly in the observation-only (13 patients), surgery-only (12 patients), and surgery/radiotherapy groups (16 patients). Eighteen patients had received only radiation and did not show a significant decrease in visual acuity. Selection criteria for the different treatment modalities as well as the exact tumor location are not addressed in this study. Thirty-two of these cases were not histologically proven. There may be some cases of sarcoid or other uncommon lesions mimicking ONSM. In our orbital series of 520 patients, there were four cases of suspected meningiomas that were histologically proven to be sarcoidosis, lymphoma, benign lymphatic hyperplasia, and aspergillosis.
Liu, et al., 13 reported on a series of five patients who had undergone stereotactic radiotherapy of 1.8 Gy fractionated doses to a cumulative dose of 45 to 54 Gy with dramatic improvement in visual acuity, visual field, and color vision within 3 months after treatment in four patients. Moyer, et al., 20 reported that a patient recovered vision after 3D conformal radiotherapy for ONSM.
Andrews, et al., 1 reported on a series of 30 patients with different meningioma locations (29% intraorbital, 36% optic canal, 3% chiasm, 18% chiasm and optic canal, and 9% middle and posterior fossae) who had undergone conventional fractionated stereotactic radiotherapy with a 6-MeV linear accelerator. Of 24 patients with useful vision before conventional fractionated stereotactic radiotherapy, 22 demonstrated either visual stability (12 patients) or improvement (10 patients). They obviously harbored planum sphenoidale and tuberculum sellae meningiomas and medial sphenoid wing tumors with secondary involvement of the optic canal. These tumors represent a different type of meningiomas associated with excellent visual outcome after surgery in contrast to primary ONSMs.
Pitz, et al., 23 reported on the results in 15 patients with ONSMs who had undergone stereotactic fractionated conformal radiation of 54 Gy. Visual acuity improved in one patient, and the visual field in six patients. Visual outcome in the other patients remained unchanged. This study is remarkable because of the visual improvement following radiation without side effects. Stereotactic 3D conformal fractionated radiation seems to be superior to conventional fractionated radiation.
Narayan, et al., 21 demonstrated the effectiveness of 3D conformal radiation therapy (14 patients) in controlling tumor growth while improving (five patients) or preserving (seven patients) vision in most patients. One patient each experienced early radiation retinopathy, orbital pain, and dry eye, and two had iritis.
Some patients with ONSMs have a stable course for many years, and a few may even experience slight improvement in their condition. The routine application of radiotherapy may unnecessarily expose some patients to complications and should be reserved for those whose visual function declines while undergoing observation. 8 Radiation retinopathy and visual loss may occur after administration of fractionated radiotherapy for ONSM. 27 Only 10 of our patients underwent postoperative radiotherapy because of symptomatic residual or recurrent tumor. Radiotherapy proved to stabilize vision in five patients and improve vision in one patient. Four patients' conditions deteriorated despite radiotherapy.
Recommendation of Treatment
Our experience with radiotherapy is still limited. After reviewing articles 1, 13, 21, 23 published in 2002 or 2003, we were compelled to rethink our surgical treatment and to declare radiotherapy as the new standard of care except in patients with intracranial mass effect. We recommend radiotherapy without biopsy as the treatment of choice in flat purely intraorbital ONSMs (Type Ia; Fig. 1 ) once mild vision loss occurs. Otherwise, patients with these tumors should only be observed. A purely intraorbital tumor manifesting as a large mass (Type Ib) around the optic nerve should be treated with surgery only if it is causing painful discomfort in the eyes and the patient has no useful vision. Otherwise, these tumors can be observed and subject to radiation once visual decline begins. Type Ic tumors with large exophytic portions should be treated surgically.
Tumors with involvement of the optic canal (Type IIa), questionable intracranial extension, and causing visual decline should be explored intradurally and then the optic canal should be decompressed. The intracranial tumor is then removed with preservation of the feeding vessels. The intraorbital portion that facilitates useful vision should not be removed. Radiotherapy should be the next treatment option for these subtotally resected tumors.
Biopsy specimens of Type IIb tumors of the apex should be obtained to verify histological features. Extradural decompression of the optic canal and superior orbital fissure is recommended as well. The intracavernous portion should be treated with radiation.
One specific indication for surgery 2 is intracranial extension (Type III) to prevent affection of the contralateral optic nerve and resect the intracranial tumor mass. Patients with these lesions should first undergo intracranial resection with decompression of the optic canal. Subtype IIIa tumors extend to the chiasm and the portion around the optic nerve should be resected. Subtype IIIb lesions reach the contralateral optic nerve and require removal from the planum sphenoidale, chiasm, and optic nerves. The intraorbital portion should be treated with radiation once visual decline occurs.
Conclusions
Intraorbital ONSMs grow intracranially and may form large intracranial masses.
Our classification system differentiates among intraorbital, intracanalicular or intrafissural, and intraorbital and intracranial types of ONSMs.
Options for treating these meningiomas include radiotherapy, surgery, and observation. If visual function is good, observation alone can be used in patients with intraorbital ONSMs until progression is noticed. The role of radiotherapy must be reevaluated and offered to adults with intraorbital ONSMs once mild vision loss occurs. Surgery involving decompression of the optic canal and intracranial tumor resection is favored for tumors with intracanalicular and intracranial extension. In case of residual or recurrent tumor growth, surgery should be followed by radiotherapy.
